RyutaroHiroseMD

Hepatobiliary Surgery, Surgical Oncology (Other than Breast), Transplantation

Chief of Division of Transplant Surgery Roger K. Giesecke Distinguished Chair in Transplant Surgery Surgical Director UW Medicine Transplant Institute Surgical Director, Scientific Registry of Transplant Recipients

Join to view full profile

Dr. Hirose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hirose's full profile

Already have an account?

Office
1959 NE Pacific St.
Box 356410
Seattle, WA 98195

Education & Training

University of California (San Francisco)Residency, Surgery, 1989 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1989

Certifications & Licensure

WA State Medical License 2023 - 2026
CA State Medical License 1991 - 2025
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons

Clinical Trials

Hyperglycemia in Renal Transplantation Start of enrollment: 2012 Aug 01
Completed
Not Applicable

Publications & Presentations

PubMed

4 citations
Geographic disparities in access to liver transplantation.
Mignote Yilma, Nicole Dalal, Sharad I Wadhwani, Ryutaro Hirose, Neil Mehta
Liver Transplantation. 2023-09-01
48 citations
A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients w...
George J. Chang, Harish D. Mahanty, Flavio Vincenti, Chris E. Freise, John P. Roberts
Clinical Transplantation. 2000-12-01
60 citations
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Neil Mehta, Jennifer L. Dodge, John P. Roberts, Ryutaro Hirose, Francis Y. Yao
Hepatology. 2018-12-13

Journal Articles

Development and Validation of an Optimized Prediction of Mortality for Candidates Awaiting Liver Transplantation
Parsia A Vagefi, Ryutaro Hirose, American journal of transplantation
Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards
Stephen Pastan, John Friedewald, Sumit Mohan, Ryutaro Hirose, Richard Formica, Clinical Transplantation

Press Mentions

Thousands of Lives Depend on a Transplant Network in Need of ‘Vast Restructuring’July 31st, 2022
Lawsuits Drive Transplant Community Debate over Liver AllocationApril 24th, 2019
VUMC Surgeon Assails National Liver Donor ProposalOctober 6th, 2016
Join now to see all